Blueprint Medicines Corporation
Hedge Funds Holdings
Last updated:
Blueprint Medicines Corporation‘s stocks are currently a part of 235 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 58.93M shares of Blueprint Medicines Corporation. Compared to the previous quarter, the number fell by -0.16% or -97.29K shares fewer. As for the holding position changes, 34.47% (81) of current hedge fund investors increased the number of shares held, 37.02% (87) of current holders sold a part of the shares held, and 28.51% (67) closed the holdings completely. 32 hedge funds are new holders of Blueprint Medicines Corporation stock in Q1 2022, it is 13.62% of total holders.
Hedge funds holding Blueprint Medicines (Q2 2017 – Q1 2022)
| Q2 2017 | 124 |
|---|---|
| Q3 2017 | 138 |
| Q4 2017 | 171 |
| Q1 2018 | 174 |
| Q2 2018 | 179 |
| Q3 2018 | 187 |
| Q4 2018 | 160 |
| Q1 2019 | 200 |
| Q2 2019 | 218 |
| Q3 2019 | 215 |
| Q4 2019 | 222 |
| Q1 2020 | 210 |
| Q2 2020 | 230 |
| Q3 2020 | 231 |
| Q4 2020 | 272 |
| Q1 2021 | 256 |
| Q2 2021 | 275 |
| Q3 2021 | 280 |
| Q4 2021 | 274 |
| Q1 2022 | 235 |
Hedge funds changes in Blueprint Medicines positions (Q2 2017 – Q1 2022)
| Q2 2017 | 25 | 54 | 34 | 34 | -23 |
|---|---|---|---|---|---|
| Q3 2017 | 29 | 51 | 40 | 14 | 4 |
| Q4 2017 | 46 | 72 | 38 | 13 | 2 |
| Q1 2018 | 30 | 55 | 63 | 25 | 1 |
| Q2 2018 | 36 | 73 | 45 | 31 | -6 |
| Q3 2018 | 36 | 65 | 62 | 26 | -2 |
| Q4 2018 | 13 | 53 | 59 | 37 | -2 |
| Q1 2019 | 48 | 68 | 58 | 10 | 16 |
| Q2 2019 | 53 | 93 | 46 | 32 | -6 |
| Q3 2019 | 26 | 88 | 56 | 28 | 17 |
| Q4 2019 | 40 | 70 | 77 | 25 | 10 |
| Q1 2020 | 36 | 97 | 55 | 46 | -24 |
| Q2 2020 | 46 | 87 | 67 | 24 | 6 |
| Q3 2020 | 27 | 81 | 81 | 26 | 16 |
| Q4 2020 | 67 | 73 | 103 | 26 | 3 |
| Q1 2021 | 34 | 101 | 93 | 46 | -18 |
| Q2 2021 | 54 | 110 | 70 | 34 | 7 |
| Q3 2021 | 41 | 98 | 93 | 30 | 18 |
| Q4 2021 | 29 | 97 | 108 | 35 | 5 |
| Q1 2022 | 32 | 81 | 87 | 67 | -32 |
Hedge funds changes in Blueprint Medicines stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 2,752,000 | 4,256,000 |
|---|---|---|
| Q3 2017 | 3,507,000 | 2,630,000 |
| Q4 2017 | 18,907,000 | 5,634,000 |
| Q1 2018 | 16,411,000 | 16,255,000 |
| Q2 2018 | 37,111,000 | 21,449,000 |
| Q3 2018 | 13,880,000 | 20,944,000 |
| Q4 2018 | 8,673,000 | 6,997,000 |
| Q1 2019 | 15,082,000 | 17,059,000 |
| Q2 2019 | 63,799,000 | 40,206,000 |
| Q3 2019 | 90,758,000 | 29,380,000 |
| Q4 2019 | 41,985,000 | 55,203,000 |
| Q1 2020 | 36,297,000 | 29,262,000 |
| Q2 2020 | 45,355,000 | 59,460,000 |
| Q3 2020 | 30,997,000 | 21,601,000 |
| Q4 2020 | 24,727,000 | 57,895,000 |
| Q1 2021 | 8,545,760 | 17,287,000 |
| Q2 2021 | 8,988,000 | 14,769,000 |
| Q3 2021 | 36,701,000 | 18,866,000 |
| Q4 2021 | 9,286,000 | 11,653,000 |
| Q1 2022 | 11,624,000 | 7,289,000 |